Preclinical assessment of broadly neutralizing #HIV antibody BNT351 with optimized pharmacokinetics and potent antiviral activity www.cell.com/iscience/ful... (open access) @cp-iscience.bsky.social Phase I trial enrolling at Johns Hopkins and two sites in Germany: clinicaltrials.gov/study/NCT073...